Abstract: An MRI phantom having an MRI compatible temperature measurement device having an MRI compatible body containing an MRI compatible fluid, wherein the device senses accurate temperature measurement within an MR Scanner environment using image processing of the contrast in signal between the areas of the image around the device and the fluid contained within the body of the device. The MRI Phantom may further include an internal expansion bladder device accomodating internal changes in pressure within the phantom, wherein the internal expansion bladder device includes frames supporting a pair of spaced membranes defining a chamber filled with a compressible gas.

Abstract: An MRI phantom having an MRI compatible temperature measurement device having an MRI compatible body containing an MRI compatible fluid, wherein the device senses accurate temperature measurement within an MR Scanner environment using image processing of the contrast in signal between the areas of the image around the device and the fluid contained within the body of the device. The MRI Phantom may further include an internal expansion bladder device accomodating internal changes in pressure within the phantom, wherein the internal expansion bladder device includes frames supporting a pair of spaced membranes defining a chamber filled with a compressible gas.

Abstract: A magnetic resonance imaging (MRI) phantom includes an outer container that includes a first portion comprising a first wall; a second portion opposingly disposed to the first portion and sealingly engaged to the first portion, the second portion including a second wall; and an internal volume bounded by the first wall and the second wall, the internal volume being hollow and configured to receive a fluid; and a sample holder disposed in the internal volume of the outer container, wherein the MRI phantom is configured to maintain a constant temperature of the internal volume. A process for acquiring an MRI image includes providing an MRI; disposing a sample member in the sample holder; disposing a fluid in the MRI phantom; disposing the MRI phantom in an MRI device; achieving thermal equilibrium in the MRI phantom at a selected temperature; and subjecting the MRI phantom to MRI imaging at the selected temperature to acquire the MRI image of the sample.

Abstract: A magnetic resonance imaging (MRI) phantom includes an outer container that includes a first portion comprising a first wall; a second portion opposingly disposed to the first portion and sealingly engaged to the first portion, the second portion including a second wall; and an internal volume bounded by the first wall and the second wall, the internal volume being hollow and configured to receive a fluid; and a sample holder disposed in the internal volume of the outer container, wherein the MRI phantom is configured to maintain a constant temperature of the internal volume. A process for acquiring an MRI image includes providing an MRI; disposing a sample member in the sample holder; disposing a fluid in the MRI phantom; disposing the MRI phantom in an MRI device; achieving thermal equilibrium in the MRI phantom at a selected temperature; and subjecting the MRI phantom to MRI imaging at the selected temperature to acquire the MRI image of the sample.

Abstract: Specific mutations in the connexin-32 gene that are associated with X-linked Charcot-Marie-Tooth (CMT) disease are disclosed. Methods of diagnosing X-linked CMT disease are also disclosed. Methods include hybridization analysis, such as Southern or Northern analysis, which use hybridization of mutant connexin-32 nucleic acid probes to connexin-32 genes; direct mutation analysis by restriction digest; sequencing of the connexin-32 gene; hybridization of an allele-specific oligonucleotide with genomic DNA; or identification of mutant connexin-32 proteins. Mutant connexin-32 nucleic acid probes are also disclosed. The mutant connexin-32 nucleic acid probes have a mutation in at least one of the following codons: 13, 16, 20, 28, 29, 41, 75, 79, 80, 85, 86, 94, 106, 124, 131, 158, 161, 169, 178, 180, 189, 191, 193, 219, 220, 230, and 267.

Abstract: Multichain polypeptides or proteins and processes for their production in cells of host organisms which have been transformed by recombinant DNA techniques. According to a first aspect of the present invention, there is provided a process for producing a heterologous multichain polypeptide or protein in a single host cell, which comprises transforming the host cell with DNA sequences coding for each of the polypeptide chains and expressing said polypeptide chains in said transformed host cell. According to another aspect of the present invention there is provided as a product of recombinant DNA technology an Ig heavy or light chain or fragment thereof having an intact variable domain. The invention also provides a process for increasing the level of protein expression in a transformed host cell and vectors and transformed host cells for use in the processes.